Tongxuekang Capsules, a national Class III new drug (a national confidential prescription). Exclusive product. Drugs listed on the National Medical Insurance List for analgesia, hemostasis, anti-inflammation, blood circulation and blood circulation. Its characteristics: strong analgesia, quick hemostasis, and good anti-inflammatory effect. This product has won the first prize of Fujian Province’s Outstanding New Product Award and the first prize of Fujian Province’s Medical Science and Technology Progress Award.
Aquiliase injection. Exclusive product. The only snake venom antithrombotic enzyme preparation that is a national Class II new drug. It is a new generation of thrombin-like enzyme that is isolated, purified and refined from Agkistrodon venom using high-tech bioengineering technology. It has the smallest molecular weight among similar products and a half-life of up to 20 hours. Aquilin injection can dissolve thrombus, inhibit thrombosis, and improve blood microcirculation. It is suitable for the treatment of acute cerebral infarction and is the preferred drug for the empirical treatment of ischemic diseases.
Patented product hawthorn essence lipid-lowering tablets. It is a nationally protected traditional Chinese medicine and the only over-the-counter drug for the treatment of hyperlipidemia that has entered the first batch of national OTC catalogs.
Loxoprofen sodium tablets (Sanyuan Shuxing). It is the latest developed national Class IV new drug and is on the National Medical Insurance List. Its analgesic, anti-inflammatory and antipyretic effects are significant.
Leflunomide tablets (Tosu) are the latest developed national first-class new drugs.
There are also more than 80 varieties and specifications of gentamicin sulfate API and penicillin powder injection series.